Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Effect of Ranibizumab on Malignant Conjunctival Neoplasia
Brief Summary:
The purpose of this study is to test the safety and tolerability of subconjunctival injection of ranibizumab in the treatment of malignant conjunctival neoplasia using the incidence and severity of adverse events.
Our secondary objective is to assess the efficacy of ranibizumab treatment on malignant conjunctival neoplasia by evaluating tumor destruction or reduction as documented by slit-lamp photography and ultrasonographic imaging and the regression of blood vessels.